Drug Testing Locations in North Dakota

Accredited Drug Testing has 140 drug testing centers in 492 ND cities.

Please select a city from the list below to find drug test centers in North Dakota.

Why North Dakota Employers Should Choose Our Drug Testing Services

Maintaining a drug-free workplace is crucial for productivity, safety, and the overall well-being of your employees. Our 140 test centers spread over 492 North Dakota cities make it easy for your company to access reliable testing services. We provide diverse testing options catering to specific industry requirements.

Our services range from pre-employment screenings to random and post-incident testing, all aimed to support your drug-free policies. By partnering with us, North Dakota employers send a strong message about their commitment to upholding safety standards and supporting their workforce's health and wellness.

Our testing facilities utilize the latest technology and adhere to rigorous quality control standards, ensuring precise and confidential results every time. This reliability allows employers to make informed decisions, minimizing risks associated with drug use in the workplace.

We understand the importance of confidentiality and manage employee data securely during testing processes. Choosing our services means you benefit from our widespread network, efficient testing, and expert support. Reinforce your commitment to a safe working environment by utilizing our comprehensive testing services.

North Dakota Drug Free Workplace Programs

North Dakota promotes a healthy work environment through various initiatives aimed at maintaining drug-free workplaces. While there isn't a specific state-mandated Drug Free Workplace Program, many businesses voluntarily implement practices to discourage drug use. These initiatives align with North Dakota’s broader efforts to foster safe and productive workplaces.

Employers in North Dakota often utilize educational resources and employee assistance programs (EAPs) to address substance abuse issues. The state's Department of Human Services provides support by connecting employers with resources to help manage these challenges. By proactively addressing substance use, North Dakota aims to ensure that workplaces remain conducive to safety and well-being.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Mobile/On-Site Drug Testing

If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.

North Dakota Laws on Drugs

North Dakota enforces stringent drug laws with severe penalties for possession, sale, and distribution of controlled substances. The state's laws categorize various drugs into schedules, determining the severity of penalties based on the schedule and amount involved. Law enforcement agencies work diligently to curb drug-related crimes. It's mandatory for pharmacies to adhere to strict regulations when dispensing prescription drugs, ensuring pharmaceutical safety and compliance.

Drug trafficking is treated with utmost seriousness in North Dakota, with penalties including hefty fines and significant prison sentences. The state places emphasis on rehabilitation and education programs aimed at reducing recidivism. Schools, workplaces, and community initiatives actively promote awareness and prevention strategies, reflecting North Dakota's commitment to combating drug abuse and protecting its residents.

North Dakota Laws on Marijuana

North Dakota has specific regulations governing the use of marijuana, primarily focusing on medical use. The state's medical marijuana program allows registered patients to access cannabis for prescribed medical conditions through licensed dispensaries. However, recreational use remains illegal, with strict penalties for possession, sale, or cultivation for non-medical purposes.

Patients participating in the medical marijuana program must adhere to specific guidelines, including registration and possession limits. The state continues to evaluate its marijuana policies, with potential reforms on the horizon as public opinion and legislative landscapes evolve. Awareness campaigns and educational resources help inform residents about the legal status and proper use of medical marijuana.

North Dakota Drug Resources

North Dakota Department of Human Services
Offers addiction treatment resources and recovery support.

North Dakota Addiction Services
Comprehensive support for individuals struggling with addiction.

Good Samaritan Society
Provides long-term care and recovery programs.

Heartview Foundation
Offers substance abuse treatment and prevention services.

Fargo Addiction Counseling
Individualized therapy and counseling for addiction recovery.

A Addiction Treatment Center
Tailored substance abuse treatment programs and support.

Burke County Social Services
Provides assistance with health and addiction issues.

Lutheran Social Services of North Dakota
Community services including addiction recovery support.

North Dakota CARES
Resources for veterans facing addiction and mental health challenges.

North Dakota Network of Care
Directory of mental health and substance abuse services.

Drug Testing Near , ND

Frequently Asked Questions

Customer Reviews